Stock Comparison
ARGX vs VRTX
argenx NV ADR and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$55.44B
$124.70B
P/E (TTM)
39.4
29.2
Forward P/E
34.0
25.8
Price/Sales
11.7
10.2
Price/Book
7.5
6.4
EV/EBITDA
33.9
24.0
Dividend Yield
—
—
Profitability
Net Margin
31.40%
35.50%
Operating Margin
30.00%
38.10%
Return on Equity
20.20%
24.20%
Return on Assets
8.86%
12.10%
Growth (YoY)
Revenue Growth
62.60%
7.80%
Earnings Growth
114.00%
61.40%
Price & Risk
Beta
-0.0
0.3
52-Week High
$934.62
$507.92
52-Week Low
$510.06
$362.50
Analyst Target
$1,041.14
$548.69
Compare ARGX and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.